Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

80 results about "Fondaparinux Sodium" patented technology

The sodium salt form of fondaparinux, a synthetic glucopyranoside with antithrombotic activity. Fondaparinux sodium selectively binds to antithrombin III, thereby potentiating the innate neutralization of activated factor X (Factor Xa) by antithrombin. Neutralization of Factor Xa inhibits its activity and interrupts the blood coagulation cascade, thereby preventing thrombin formation and thrombus development. (NCI05)

Preparation method of fondaparinux sodium injection composition

The invention discloses a preparation method of a fondaparinux sodium injection composition. The preparation method comprises the following steps of 1) according to a prescription of the fondaparinuxsodium injection composition, weighing all materials by prescription dosage; 2) taking fondaparinux sodium and sodium chloride, combining, then adding injection water with the weight being 75-85% of the total weight, after stirring and dissolving, adopting a pH regulator to regulate the pH to 5-8, then adding remaining injection water, stirring and mixing uniformly to obtain liquid medicine; 3) filling prepared liquid medicine, and carrying out high-temperature sterilization, cooling, lamp inspection, package and inspection to obtain the fondaparinux sodium injection composition. The fondaparinux sodium injection composition prepared by the invention has the advantages that by optimizing the pH and sterilization process of the fondaparinux sodium injection composition, the obtained solution is good in clarity and conforms to all detection requirements of the injection liquid item in Chinese pharmacopoeia, so that the quality stability of products is greatly improved, the crystallization and the turbidity of the solution are reduced, and the generation of impurities is reduced.
Owner:SHANGHAI SCIENPHARM CO LTD

Intermediate of fondaparinux sodium and preparation method for intermediate and fondaparinux sodium

The invention discloses an intermediate of fondaparinux sodium and a preparation method for the intermediate and the fondaparinux sodium. The preparation method is as follows: a protective pentasaccharide compound III is subjected to esterolysis reaction at presence of sodium hydroxide, the hydrolyzed compound is sulfated to obtain a compound IV, an intermediate compound I reacts with SO3 in pyridine at the temperature of 50 DEG C for 18 h and sulfated to obtain a compound II, the compound II is subjected to catalytic hydrogenation in methyl alcohol and water with palladium hydroxide or a palladium carbon catalyst to enable the compound II to get rid of all R groups to obtain the fondaparinux sodium. According to the invention, the reactions are high in selectivity and specificity and the productive rate of each reaction can reach about 90%; the obtained crude product of the intermediate is relatively high in purity, easy to supervise and trace, and relatively high in productive rate without need for purification; the operation is simple and the reproducibility is good; final products are obtained through the catalytic hydrogenation with benzyl groups and protecting groups removed, the final products are high in purity and suitable for large-scale industrial production, the production cost is greatly reduced, and the products are competitive in markets.
Owner:HEBEI CHANGSHAN BIOCHEM PHARMA

Automatic preparation method of fondaparinux sodium pentasaccharide intermediate

The invention relates to an automatic preparation method of a fondaparinux sodium pentasaccharide intermediate. The method is based on an automatic preparation device. According to the method, automatic preparation of three components (D+EF+GH) is realized through automatic sample injection and automatic sampling and monitoring, the fully-protected fondaparinux sodium pentasaccharide intermediate(formula I) is obtained, and automatic synthesis of the fondaparinux sodium pentasaccharide intermediate is realized, so that the manpower can be saved, the efficiency and productivity are improved, and relatively high safety and reproducibility are achieved; direct online monitoring can be realized, the real-time state of a reaction is convenient to optimize and monitor, and meanwhile, the automatic temperature control can better meet the requirements of the reaction on heating and cooling; a pre-activation one-kettle mode is adopted, so that the separation frequency is reduced, and the operation is convenient; and a common ester protecting group is selected, relatively high stereoselectivity and yield are achieved, a universal deprotection method can be used, and the method has importantsignificance in reducing the production cost of fondaparinux sodium and achieving large-scale production. The definition of each substituent in the formula I is the same as the definition in the specification.
Owner:PEKING UNIV

Preparation method of Fondaparinux sodium injection

The invention discloses a preparation method of a Fondaparinux sodium injection. The method comprises the following steps: (1) weighing each raw material and subsidiary material according to a prescription amount according to a prescription of the Fondaparinux sodium injection; (2) adding part of water for injection into a liquid preparing container, performing heating to 100 DEG C, performing cooling to room temperature, then adding an active ingredient and an isotonic regulator, and performing stirring and dissolving; (3) adjusting a pH value of a solution obtained in the step (2) to 6.5-7.5with a pH regulator, and adding the remaining water for injection to make a constant volume; (4) filtering a drug solution through a 0.22 micron micro-porous filter membrane or filter element; (5) filling a filtered drug solution into a pre-filled syringe, and performing moist heat sterilization at 121-125 DEG C for 12-15 min; and (6) performing lamp inspection, packaging and inspection after sterilization to obtain the Fondaparinux sodium injection. The preparation method of the invention meets requirements of drug registration regulations, has few impurities, has good stability, has high sterility assurance level, and is suitable for industrial production.
Owner:YANTAI DONGCHENG PHARMA GRP

Preparation method of fondaparinux sodium monosaccharide intermediate

The invention discloses a preparation method of a fondaparinux sodium monosaccharide intermediate. The preparation method comprises the following steps: (1) in the presence of an acid-binding agent, carrying out esterification reaction on a compound as shown in a formula (I) and a substituent sulfonic anhydride and/or a substituent sulfonyl halogen to generate a compound as shown in a formula (II); (2) carrying out a ring opening reaction on the compound as shown in the formula (II) in an acidic condition to generate a compound as shown in a formula (III); (3) carrying out benzylation reactionon the compound as shown in the formula (III) and benzyl monohalide in an alkaline condition to generate a compound as shown in a formula (IV); and (4) carrying out an azido reaction on the compoundas shown in the formula (IV) and alkali metal azide salt to generate a compound as shown in a formula (V) and caring out inner ether ring opening and acetylation reaction on the compound as shown in the formula (V) in a mixed solution of acetic anhydride and trifluoroacetic acid to generate a compound as shown in a formula (VI). The method can be used for obtaining an ideal product yield, and theraw materials are cheap, easily available and relatively few in three wastes. The formulae are as shown in the description.
Owner:江苏美迪克化学品有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products